OBJECTIVE: To assess whether chronic disease is a barrier to screening
for breast and cervical cancer. DESIGN: Structured medical record rev
iew of a retrospectively defined cohort. SETTING: Two primary care cli
nics of one academic medical center. PATIENTS: All eligible women at l
east 43 years of age seen during a B-month period in each of the two s
tudy clinics (n = 1,764), MEASUREMENTS AND MAIN RESULTS: Study outcome
s were whether women had been screened: for mammogram, every 2 years f
or ages 50-74; for clinical breast examinations (CBEs), every year for
all ages; and for Pap smears, every 3 years for ages under 65. An ind
ex of comorbidity, adapted from Charlson (0 for no disease, maximum in
dex of 8 among our patients), and specific chronic diseases were the m
ain independent variables. Demographics, clinic use, insurance, and cl
inical data were covariates. In the appropriate age groups for each te
st, 58% of women had a mammogram, 43% had a CBE, and 66% had a Pap sme
ar. As comorbidity increased, screening rates decreased (p < .05 for l
inear trend). After adjustment, each unit increase in the comorbidity
index corresponded to a 17% decrease in the likelihood of mammography
(p = .005), 13% decrease in CBE (P = .006), and 20% decrease in Pap sm
ears (p = .002). The rate of mammography in women with stable angina w
as only two fifths of that in women without. CONCLUSIONS:Among women w
ho sought outpatient care, screening rates decreased as comorbidity in
creased. Whether clinicians and patients are making appropriate decisi
ons about screening is not known.